Evidence map›Paper›PMID 23325890›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

IL-21 and CD40L synergistically promote plasma cell differentiation through upregulation of Blimp-1 in human B cells.

B Belinda Ding, Enguang Bi, Hongshan Chen, J Jessica Yu, B Hilda Ye

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 137 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Pro-Resolving Macrophage-Induced IL-35International journal of molecular sciences · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Metabolic fitness of IgAMucosal immunology · 2024
    Article
  11. Article
  12. Article
  13. TACI and endogenous APRIL in B cell maturation.Clinical immunology (Orlando, Fla.) · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Optimized Protocols forFrontiers in immunology · 2022
    Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

B Belinda DingDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Enguang Bi
Hongshan Chen
J Jessica Yu
B Hilda Ye
Albert Einstein College of Medicine · US

Funding

ROLE OF THE BCL 6 PROTO ONCOGENE IN B CELL LYMPHOMASR01CA085573 · NCI · YESHIVA UNIVERSITY · PI YE, BIHUI HILDA · 2000 to 2010
$3.4M
NCI NIH HHS R01 CA085573NCI NIH HHS R01 CA85573
6 · The paper itself

Abstract

After undergoing Ig somatic hypermutation and Ag selection, germinal center (GC) B cells terminally differentiate into either memory or plasma cells (PCs). It is known that the CD40L and IL-21/STAT3 signaling pathways play critical roles in this process, yet it is unclear how the B cell transcription program interprets and integrates these two types of T cell-derived signals. In this study, we characterized the role of STAT3 in the GC-associated PC differentiation using purified human tonsillar GC B cells and a GC B cell-like cell line. When primary GC B cells were cultured under PC differentiation condition, STAT3 inhibition by AG490 prevented the transition from GC centrocytes to preplasmablast, suggesting that STAT3 is required for the initiation of PC development. In a GC B cell-like human B cell line, although IL-21 alone can induce low-level Blimp-1 expression, maximum Blimp-1 upregulation and optimal PC differentiation required both IL-21 and CD40L. CD40L, although having no effect on Blimp-1 as a single agent, greatly augmented the amplitude and duration of IL-21-triggered Jak-STAT3 signaling. In the human PRDM1 locus, CD40L treatment enhanced the ability of STAT3 to upregulate Blimp-1 by removing BCL6, a potent inhibitor of Blimp-1 expression, from a shared BCL6/STAT3 site in intron 3. Thus, IL-21 and CD40L collaborate through at least two distinct mechanisms to synergistically promote Blimp-1 activation and PC differentiation.

Indexed as

Adjuvants, ImmunologicB-Lymphocyte SubsetsCD40 LigandCell DifferentiationCell Line, TumorHumansInterleukin-21InterleukinsJanus KinasesMolecular Sequence DataOrgan Culture TechniquesPalatine TonsilPlasma CellsPositive Regulatory Domain I-Binding Factor 1Repressor ProteinsSTAT3 Transcription FactorAdjuvants, ImmunologicCD40 LigandInterleukin-21InterleukinsJanus KinasesPositive Regulatory Domain I-Binding Factor 1PRDM1 protein, humanRepressor ProteinsSTAT3 protein, humanSTAT3 Transcription Factor

Identifiers

PMID23325890
PMCPMC3563840
OpenAlexW2139361228

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.